This guideline updates the 2017 guideline on clinical indications and drug regimens for PrEP and PEP in Canada and contains 31 recommendations and 10 good practice statements.
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.